BRASIER BARBARA L 4
4 · MOLINA HEALTHCARE, INC. · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
Molina Healthcare (MOH) Director Barbara L. Brasier Receives 405-Share Award
What Happened
Barbara L. Brasier, a director of Molina Healthcare, received a grant of 405 shares of Molina common stock on April 1, 2026. The shares were granted at the closing price of $135.82 per share, for an aggregate value of approximately $55,007. This transaction is an equity award (transaction code A) granted as part of director compensation under the company's equity plan.
Key Details
- Transaction date: 2026-04-01; Filing date: 2026-04-02 (filed timely).
- Shares granted: 405 shares at $135.82 per share; total value ≈ $55,007.
- Shares owned after transaction: Not reported in the provided filing.
- Footnotes: Grant made under the Issuer's 2025 Equity Incentive Plan (F1). Annual director equity is $220,000 with one-quarter ($55,000) granted each quarter; April 1, 2026 closing price ($135.82) resulted in 405 shares (F2, F3).
- Transaction type: Award/grant (A) — a compensation grant, not an open-market purchase.
Context
This was a routine director equity award as compensation, not a market purchase or sale. Such grants compensate service and do not by themselves signal an insider buying or selling for investment purposes; purchases are typically more informative of sentiment.
Insider Transaction Report
- Award
Common Stock
[F1][F2][F3]2026-04-01$135.82/sh+405$55,007→ 5,581 total
Footnotes (3)
- [F1]Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
- [F2]The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.
- [F3]Represents the closing price of the Issuer's common stock on April 1, 2026.